ETH
CEROW

Exos TFP Holdings’s CERo Therapeutics Warrants CEROW Stock Holding History

Exos TFP Holdings’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$93 Hold
3,700
– – ﹤0.01% 184
2023
Q3 		$265 Hold
3,700
– – ﹤0.01% 218
2023
Q2 		$226 Hold
3,700
– – ﹤0.01% 229
2023
Q1 		$148 Hold
3,700
– – ﹤0.01% 442
2022
Q4 		$159 Buy
+3,700
New +$195 ﹤0.01% 529

Other funds holding CEROW

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Exos TFP Holdings's CEROW Position: Q4 2023 in Review

Exos TFP Holdings held its CERo Therapeutics Warrants (CEROW) position steady in Q4 2023 at 3,700 shares worth $93. The position accounts for ﹤0.01% of the portfolio, ranked #184.

Exos TFP Holdings first reported a position in CEROW in Q4 2022 and has held it in 5 quarters since. The position peaked at $265 in Q3 2023. 40 funds tracked by Wall St. Rank hold CEROW as of Q4 2023.

  • Exos TFP Holdings held 3,700 shares of CERo Therapeutics Warrants worth $93 as of Q4 2023.
  • Exos TFP Holdings left its CERo Therapeutics Warrants share count unchanged in Q4 2023.
  • CERo Therapeutics Warrants made up ﹤0.01% of Exos TFP Holdings's portfolio in Q4 2023, its #184 holding.
  • Exos TFP Holdings first reported a position in CERo Therapeutics Warrants in Q4 2022 and has held it in 5 quarters since.
  • Exos TFP Holdings's CERo Therapeutics Warrants position peaked at $265 in Q3 2023.
  • 40 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2023.

Based on Exos TFP Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.